Exane Derivatives’s PVH PVH Stock Holding History

Exane Derivatives’s Portfolio PVH Stock Details PVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-4	Closed	-$576	–	699
2018 Q1	$576	Sell	4 -11,577	-100%	-$1.69M	﹤0.01%	498
2017 Q4	$1.59M	Sell	11,581 -1,911	-14%	-$250K	0.27%	63
2017 Q3	$1.7M	Buy	+13,492	New	+$1.64M	0.32%	61

Other funds holding PVH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Exane Derivatives's PVH Position: Q2 2018 in Review

Exane Derivatives sold out of PVH (PVH) in Q2 2018, closing a stake of 4 shares — an estimated $576 sold.

Exane Derivatives first reported a position in PVH in Q3 2017 and held it in 3 quarters. The position peaked at $1.7M in Q3 2017. 546 funds tracked by Wall St. Rank hold PVH as of Q2 2018.

Exane Derivatives reported no remaining PVH position as of Q2 2018 after selling out during the quarter.
Exane Derivatives sold 4 PVH shares in Q2 2018, an estimated $576.
Exane Derivatives first reported a position in PVH in Q3 2017 and held it in 3 quarters.
Exane Derivatives's PVH position peaked at $1.7M in Q3 2017.
546 funds tracked by Wall St. Rank held PVH as of Q2 2018.

Based on Exane Derivatives's 13F filing for Q2 2018, filed 19 Jul 2018.